CompletedPhase 3NCT00003805
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Michel P. Glauser, MDCentre Hospitalier Universitaire Vaudois
- Intervention
- piperacillin sodium(drug)
- Enrollment
- 859 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 1997
Study locations (28)
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
- Boston Medical Center, Boston, Massachusetts, United States
- Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
- Hopital Universitaire Erasme, Brussels, Belgium
- Institut Jules Bordet, Brussels (Bruxelles), Belgium
- Cliniques Universitaires Saint-Luc, Brussels (Bruxelles), Belgium
- Kingston General Hospital, Kingston, Ontario, Canada
- Ottawa Regional Cancer Center - General Division, Ottawa, Ontario, Canada
- Masaryk University Hospital, Brno, Czechia
- Turku University Central Hospital, Turku, Finland
- CHR de Besancon - Hopital Saint-Jacques, Besançon, France
- Klinikum der Universitaet Ulm, Ulm, Germany
- Hellenic Institute for Cancer-Saint Savas Hospital, Athens, Greece
- Athens University-Laikon General Hospital, Athens, Greece
- Metaxa's Memorial Cancer Hospital, Piraeus, Greece
- +13 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003805 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.